DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gim, Hyo Jin | ko |
dc.contributor.author | Li, Hua | ko |
dc.contributor.author | Jeong, Ji Hye | ko |
dc.contributor.author | Lee, Su Jeong | ko |
dc.contributor.author | Sung, Mi-Kyung | ko |
dc.contributor.author | Song, Mi-Young | ko |
dc.contributor.author | Park, Byung-Hyun | ko |
dc.contributor.author | Oh, Soo Jin | ko |
dc.contributor.author | Ryu, Jae-Ha | ko |
dc.contributor.author | Jeon, Raok | ko |
dc.date.accessioned | 2024-03-22T07:01:16Z | - |
dc.date.available | 2024-03-22T07:01:16Z | - |
dc.date.created | 2024-03-21 | - |
dc.date.created | 2024-03-21 | - |
dc.date.issued | 2015-07 | - |
dc.identifier.citation | BIOORGANIC MEDICINAL CHEMISTRY, v.23, no.13, pp.3322 - 3336 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | http://hdl.handle.net/10203/318784 | - |
dc.description.abstract | A series of alkoxy-3-indolylacetic acid analogs has been discovered as peroxisome proliferator-activated receptor (PPAR) agonists. Structure-activity relationship study indicated that PPAR alpha/gamma/delta activities were dependent on the nature of the hydrophobic group, the attachment position of the alkoxy linker to the indole ring, and N-alkylation of indole nitrogen. Some compounds presented significant PPAR gamma/delta activity and molecular modeling suggested their putative binding modes in the ligand binding domain of PPAR gamma. Of these, compound 51 was selected for in vivo study via an evaluation of microsomal stability in mouse and human liver. Compound 51 lowered the levels of fasting blood glucose, insulin, and HbA1c without gain in body weight in db/db mice. When compound 51 was treated, hepatic triglycerides level and the size of adipocytes in white adipose tissue of db/db mice were also reduced as opposed to treatment with rosiglitazone. Taken together, compound 51 shows high potential warranting further studies in models for diabetes and related metabolic disorders and may be in use as a chemical tool for the understanding of PPAR biology. (C) 2015 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists | - |
dc.type | Article | - |
dc.identifier.wosid | 000355848900039 | - |
dc.identifier.scopusid | 2-s2.0-84983150592 | - |
dc.type.rims | ART | - |
dc.citation.volume | 23 | - |
dc.citation.issue | 13 | - |
dc.citation.beginningpage | 3322 | - |
dc.citation.endingpage | 3336 | - |
dc.citation.publicationname | BIOORGANIC MEDICINAL CHEMISTRY | - |
dc.identifier.doi | 10.1016/j.bmc.2015.04.046 | - |
dc.contributor.localauthor | Park, Byung-Hyun | - |
dc.contributor.nonIdAuthor | Gim, Hyo Jin | - |
dc.contributor.nonIdAuthor | Li, Hua | - |
dc.contributor.nonIdAuthor | Jeong, Ji Hye | - |
dc.contributor.nonIdAuthor | Lee, Su Jeong | - |
dc.contributor.nonIdAuthor | Sung, Mi-Kyung | - |
dc.contributor.nonIdAuthor | Song, Mi-Young | - |
dc.contributor.nonIdAuthor | Oh, Soo Jin | - |
dc.contributor.nonIdAuthor | Ryu, Jae-Ha | - |
dc.contributor.nonIdAuthor | Jeon, Raok | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | PPAR | - |
dc.subject.keywordAuthor | Agonist | - |
dc.subject.keywordAuthor | Indolylacetic acid | - |
dc.subject.keywordAuthor | Metabolic disease | - |
dc.subject.keywordPlus | NONALCOHOLIC FATTY LIVER | - |
dc.subject.keywordPlus | PPAR-GAMMA | - |
dc.subject.keywordPlus | SKELETAL-MUSCLE | - |
dc.subject.keywordPlus | HEART-FAILURE | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | DELTA | - |
dc.subject.keywordPlus | MODULATORS | - |
dc.subject.keywordPlus | ROLES | - |
dc.subject.keywordPlus | THIAZOLIDINEDIONES | - |
dc.subject.keywordPlus | ROSIGLITAZONE | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.